GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
Show more...
FAQ
GT Biopharma Common Stock 今天的股價是多少?▼
GTBP 目前價格為 $8.83 USD,過去 24 小時上漲了 +2.56%。在圖表上更密切關注 GT Biopharma Common Stock 股價表現。
GT Biopharma Common Stock 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 XNAS 交易所,GT Biopharma Common Stock 的股票以代號 GTBP 進行交易。
GT Biopharma Common Stock 的股價在上漲嗎?▼
GTBP 股票較上週上漲 +3,472.61%,本月上漲 +2,808.78%,過去一年 GT Biopharma Common Stock 上漲 +969.57%。
GT Biopharma Common Stock 的市值是多少?▼
今天 GT Biopharma Common Stock 的市值為 15.93M
GT Biopharma Common Stock 下一次財報日期是什麼時候?▼
GT Biopharma Common Stock 將於 November 11, 2026 公布下一次財報。
GT Biopharma Common Stock 上一季度的財報如何?▼
GTBP 上一季度的財報為每股 -3 USD,預估為 -2 USD,帶來 -50% 的驚喜。下一季度的預估財報為每股 不適用 USD。
GT Biopharma Common Stock 去年的營收是多少?▼
GT Biopharma Common Stock 去年的營收為 0USD。
GT Biopharma Common Stock 去年的淨利是多少?▼
GTBP 去年的淨收益為 -34.45MUSD。
GT Biopharma Common Stock 有多少名員工?▼
截至 September 14, 2026,公司共有 1 名員工。
GT Biopharma Common Stock 位於哪個產業?▼
GT Biopharma Common Stock從事於Health & Wellness產業。
GT Biopharma Common Stock 何時完成拆股?▼
GT Biopharma Common Stock 上次拆股發生於 February 05, 2024,比例為 1:30。
GT Biopharma Common Stock 的總部在哪裡?▼
GT Biopharma Common Stock 的總部位於 美國 的 SAN FRANCISCO。